Female sex | 0.4 (0.2–1.0) | 0.060 | 0.2 (0.1–0.9) | 0.033 |
Age per 5 years | 0.8 (0.6–1.0) | 0.019 | | |
Chronic respiratory disease | 0.2 (0.1–0.6) | 0.005 | | |
Neurological disease | 0.2 (0.1–0.6) | 0.005 | | |
Current smoking | 0.3 (0.1–0.5) | <0.001 | 0.4 (0.1–0.9) | 0.033 |
Previous antibiotic | 3.5 (1.7–7.1) | <0.001 | | |
Time with symptoms >5 days | 4.8 (2.1–10.7) | <0.001 | | |
HAART | 0.2 (0.1–0.5) | <0.001 | | |
Cotrimoxazole prophylaxis | 0.2 (0.1–0.4) | <0.001 | 0.1 (0.04–0.5) | 0.003 |
Pleuritic pain | 0.4 (0.2–0.9) | 0.023 | | |
Creatinine <1.5 mg·dL−1 | 2.8 (0.8–9.4) | 0.095 | | |
C-reactive protein <12 mg·dL−1 | 3.2 (1.5–6.9) | 0.002 | | |
WBCs ≤4000×109 per L | 4.4 (2.2–9.0) | <0.001 | 3.7 (1.2–11.5) | 0.023 |
LDH ≥598 U·L−1 | 23.4 (9.4–58.1) | <0.001 | 12.9 (4.2–39.7) | <0.001 |
Multilobar infiltration | 11.9 (4.8–29.2) | <0.001 | 5.8 (1.9–19.5) | 0.002 |
CD4+ count <200 cells per mm3 | 10.5 (4.5–24.6) | <0.001 | | |
HIV RNA ≥200 copies per mL | 10.1 (2.4–42.7) | 0.002 | | |
Co-infection with HCV | 0.3 (0.2–0.7) | 0.005 | | |
Diagnosis of HIV infection during the episode of pneumonia | 6.2 (3.1–12.4) | <0.001 | | |